Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors - Na...

Conotoxin αD-GeXXA utilizes a novel strategy to antagonize nicotinic acetylcholine receptors  Nature

Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors - Frontiers

Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors  Frontiers

Two-faced TIRs trip the immune switch - PNAS

Two-faced TIRs trip the immune switch  PNAS

Plasma physics sets upper limit on the strength of ‘dark electromagnetism’ - Physics World

Plasma physics sets upper limit on the strength of ‘dark electromagnetism’  Physics World

αDβ2 as a novel target of experimental polymicrobial sepsis - Frontiers

αDβ2 as a novel target of experimental polymicrobial sepsis  Frontiers

Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based r...

Molecular mechanisms of the anti-cancer drug, LY2874455, in overcoming the FGFR4 mutation-based resistance  Nature

Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization - Nature

Mechanistic basis of Nek7 activation through Nek9 binding and induced dimerization  Nature